Clinical trial · Observational
Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients
NCT00727883CI-TRIAL-00004183SOSTAcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Retrospective observational trial on reasons for withdraw of Adjuvant Tamoxifen in Breast Cancer patients
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- 1
- description
- Post menopausal women treated with adjuvant TAM for breast cancer
Primary outcomes (1)
- measure
- incidence of withdraw from adjuvant Tamoxifen due to Tam related AEs
- timeFrame
- January 2003-December 2004
Secondary outcomes (1)
- measure
- Types of TAM related AE
- timeFrame
- January 2003-December 2004
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: * Breast Ca Patients with surgery and withdraw of adjuvant treatment with Tamoxifen for Tam related AEs * Documented reasons for treatment withdrawal Exclusion Criteria: * enrollment in other studies * treatment withdraw for other causes than Tam related AEs
References
Publications (0)
Data not yet available
No reference posted for this study.